Cargando…

Management of inflammatory bowel disease in poor responders to infliximab

Infliximab (IFX) is an effective treatment for inducing and maintaining response in Crohn’s disease and ulcerative colitis patients. Some patients present lack of response or loss of response to IFX during maintenance therapy. Empirical management with combination therapy with an immunomodulator, IF...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerra, Iván, Bermejo, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171998/
https://www.ncbi.nlm.nih.gov/pubmed/25258548
http://dx.doi.org/10.2147/CEG.S45297